DUE TO FAILURE OF AMGEN CONTRACT SALES ORGANIZATION "Originally projected to expand their Praluent sales force in Feb 2016, Regeneron has decided not to hire an additionally 500+ reps next year based upon Amgen's minimal sales with such a large inexperienced, highly unskilled, low paid contract sales force. Praluent remains a potential blockbuster medicine, however, too many sales reps do not necessarily translate to an increase in sales."-WSJ
